Transforming ALS Diagnosis and Drug Discovery
Breakthrough diagnosis and treatments
—reimagining ALS care with cutting-edge technology.
About SONoALS
Mission-Driven Science
SONoALS, Inc. is a pioneering startup to redefine how ALS is diagnosed and treated. Our mission is to bring non-invasive, data-rich monitoring to the frontlines of neurodegenerative disease research. The team unites clinical neuroscience and biomedical engineering to make that mission a reality.
Breakthrough Technology
Wearable Ultrasound × AI-Powered Analysis
Revolutionary ultrasound technology combined with AI-powered analysis for Amyotrophic Lateral Sclerosis (ALS) monitoring and diagnosis.
News & Press
Latest updates and achievements from SONoALS
JETRO J-StarX HealthTech Gateway General in APAC/Europe
Nov 2024 - Jun 2025
Co-hosted by the Japan External Trade Organization (JETRO) and Medtech Actuator
Dispatched to Sydney from May 3–10, 2025, to attend the Aus Medtech Conference. Participated in a pitch at the Medtech Actuator competition and talk session on June 24, 2025.
MedTech Angels Season 4
Dec 2024 - May 2025
SONoALS won both the Grand Prize and the LINK-J Life Science Award at the prestigious "MedTech Angels Season 4 DemoDay" on May 28, 2025
HVC KYOTO 2024 Healthcare Venture Conference
May 2024 - Jul 2024
Presented in a special talk session organized by Japan's Ministry of Health, Labour and Welfare (MEDISO) as part of the Healthcare Venture Conference.
Get in Touch
Ready to learn more about our revolutionary ALS technology? Let's connect.
Company Information
Address
WALLSQUARE Kitanozaka
2-13-15 Yamamoto Ave., Chuo Ward
Kobe City, Hyogo 650-0003, Japan
chizu@sonoals.com
Established
May 2025
Tadashi Kojima
SONoALS